Navigation Links
New Herbal-Based Sexual Supplement Hits Market Today
Date:2/8/2016

NEW YORK, Feb. 8, 2016 /PRNewswire/ -- Labvantage Lx, a newcomer to the dietary supplement market, today announces its first male sexual enhancement product, EnduramenT. Setting a new standard in herbal-based enhancement, EnduramenT combines proven ethnobotanicals with a patented biomedical breakthrough molecule that promotes the controlled release of nitric oxide, the chemical compound responsible for many biological functions including erectile function.

Forgoing the use of prescription medications, scientists working on EnduramenT discovered the synergy of the nitric oxide and blood flow stimulating effects of old world ethnobotanicals with the nitric oxide releasing power of the patented molecule VEEN. The EnduramenT formula combines these proven ethnobotanicals with VEEN, which has been shown in clinical studies to improve nitric oxide levels in a controlled manner in response to various stimuli, among them increased blood pressure, thus restoring youthful vigor and function in the body.

EnduramenT
EnduramenT

An independent survey of men ages 30-60 showed that the patent pending EnduramenT formula addresses the problems of male desire and performance by combining two major botanicals, Muira puama extract with Pueraria lobata extract. This fast acting formulation increases libido while enhancing erection quality - providing a firmer, longer-lasting erection and overall improved sexual experience for both partners. In this recent consumer study conducted on behalf of Labvantage Lx, 89% of users reported their sexual partners as also having a marked improvement in satisfaction with the addition of EnduramenT.

EnduramenT is an herbal-based scientifically formulated product using cutting edge desiccated liposomal delivery technology to deliver effective amounts of the active ingredients quickly into the blood stream through the highly vascularized oral mucosa. The formula is designed to be taken only minutes prior to sexual activity and its onset can be felt within minutes of its absorption under the tongue. Upon taking this supplement as directed, 89% of healthy men ages 30-60 experienced a harder, firmer and longer lasting erection.

Labvantage Lx is committed to removing the guesswork from the herbal supplement market by offering only herbal-based products that have yielded positive results according to detailed testimonials. EnduramenT is available to purchase online at http://www.labvlx.com/.

About Labvantage Lx:
Labvantage Lx Corporation is committed to developing, manufacturing and marketing effective herbal-based supplements that are proven to deliver results based on our clinically tested testosterone-enhancing formula. With the intent to redefine anti-aging, male enhancement, women's sexual health and fitness, Labvantage Lx applies real science to create safe, superior alternatives to prescription drugs and unproven over-the-counter supplements that address these concerns. For more information about our products, please visit http://www.labvlx.com/.

Press Contact: The Narrative Group
Anna MacLellan / (646) 435-9810
Email 

 

Photo - http://photos.prnewswire.com/prnh/20160208/330743 
Logo - http://photos.prnewswire.com/prnh/20160208/330744LOGO 


'/>"/>
SOURCE Labvantage Lx
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Palatin Technologies Strengthens Intellectual Property Surrounding Use of Bremelanotide for Female Sexual Dysfunction
2. Male and Female Sexual Dysfunctions: Drug Market Report and Forecasts 2016-2026
3. Need to Prevent Sexually Transmitted Diseases (STIs) for Public Health Drives Global Contraceptives Market: Transparency Market Research
4. U.S. Sexually-Transmitted Diseases (STD) Diagnostic Testing Market 2016 - Supplier Shares and Country Forecasts
5. United States Sexually-Transmitted Diseases (STD) Diagnostic Testing Market 2016: Emerging Opportunities and Growth Strategies for Suppliers
6. S1 Biopharma Supports FDA Approval of First-Ever Treatment for Hypoactive Sexual Desire Disorder
7. S1 Biopharma Supports FDA Advisory Committees Recommendation to Approve the First-Ever Treatment for Hypoactive Sexual Desire Disorder
8. Palatin Supports FDA Advisory Committees Recommendation to Approve the First-Ever Treatment for Hypoactive Sexual Desire Disorder
9. Even The Score Marks 17th Viagra Anniversary with Release of New Letter from Members of Congress to FDA Calling for Equity in Sexual Health
10. Elsevier Announces Publishing Agreement with the International Society for Sexual Medicine
11. Spinal surgery diminishes low back pain, improves sexual function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2019)... ... April 18, 2019 , ... ChronWell, ... it has been invited to participate in the inaugural “RIMS Tech, the Insurtech ... coming to Boston April 28th through May 1st. , The competition, which ...
(Date:4/18/2019)... ... April 18, 2019 , ... ... shaping Cultural Beliefs®, and solving Accountability Gaps, and that is now introducing cutting-edge ... team as a service provider to the FDA. This award, estimated at ...
(Date:4/17/2019)... ... April 17, 2019 , ... Salt Lake Community ... Doctorate recipients. They will receive their degrees at SLCC’s May 3 Commencement at the ... executive vice president over Corporate Affairs and Miller Family Philanthropy. Richards is president and ...
Breaking Medicine Technology:
(Date:4/18/2019)... ... April 18, 2019 , ... She went from learning disabled to honor ... her mother, Cheryl Reilly. Those “goofy tests,” performed by Deborah Zelinsky, O.D. , ... years old, had such narrow range of visual awareness, she could only see what ...
(Date:4/17/2019)... ... April 17, 2019 , ... With Fentanyl overdose deaths continuing to ... curb the death toll by looking for an alternative to naloxone. Researchers are presenting ... Exposition this week. , Naloxone (often known by the name brand Narcan) has been ...
(Date:4/17/2019)... ... April 17, 2019 , ... The ... new initiative this April to designate April 19th as World IBS Day to ... research & healthcare professionals in their pursuit to find treatments. Irritable Bowel Syndrome ...
(Date:4/17/2019)... (PRWEB) , ... April 17, 2019 , ... ... focus on advances in revolutionary diagnostic technologies. This episode is scheduled to air ... In this segment, Innovations will focus on Credo Biomedical Pte. Ltd. (Credo Biomedical), ...
(Date:4/17/2019)... Calif. (PRWEB) , ... April 17, 2019 , ... Student-athletes ... edge thanks to a 2019 Thomas R. Brown Athletics Grant from California ... equipment, improve player safety, and provide uniforms. , The grant is named for ...
Breaking Medicine News(10 mins):